Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.
AML News — July 28, 2021
Graft vs host disease affects up to 50% of patients after allogeneic stem cell transplant and 10-15% of these patients suffer from severe symptoms. A new drug called Rezurock will be available at the end of August 2021 to provide relief to those struggling with severe graft vs host disease.
Life with AML—July 20, 2021
Fall prevention should be a key area of focus for older patients with AML. Learn from physical therapist, Beth Travis about the importance of fall prevention and steps you can take to stay safely on your feet.
AML News—July 16, 2021
Adding palliative care healthcare professionals to your team during induction chemotherapy for AML can increase your ability to cope, improve your quality of life and reduce feelings of depression and anxiety
Life with AML—July 14, 2021
Exercise even 3 times a week for AML patients can reduce fatigue, depression and inflammatory markers. So let's get moving today!
AML News—July 8, 2021
Venetoclax improves treatment outcomes in many patients with AML by blocking the BCL-2 protein. Learn about the benefits of using venetoclax in combination with other therapies and use our AML Clinical Trial Finder to explore what venetoclax clinical trials are going on right now that you might be able to participate in!
Life with AML—July 7, 2021
With AML treatment comes side effects. Some may experience them more strongly than others, but it’s always good to be prepared and have a plan to help if and when symptoms occur. Learn how to manage common symptoms that occur as a result of AML treatment.